Among the different stages of bladder cancer, ApoA-1 showeda lower expression (<20 ng/mL) with each subsequent higher stage, namely Ta (47.6%), T1 (52.3%), and T2 (70%). The gene discussed is APOA1; the disease is urinary bladder cancer.